ClinicalTrials.Veeva

Menu

Tailored Anti-Inflammatory (A-I) Diet for Americans With Ulcerative Colitis (UC)

University of Miami logo

University of Miami

Status

Enrolling

Conditions

Ulcerative Colitis

Treatments

Behavioral: Feedback sessions
Behavioral: Dietary counseling
Behavioral: Diet guidance sessions
Behavioral: Catered diet

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT06784323
1R01DK140964-01 (U.S. NIH Grant/Contract)
20240857

Details and patient eligibility

About

The purpose of this study is to test the effect of an anti-inflammatory diet that incorporates native foods of the American diet on disease remission in American patients with Ulcerative Colitis (UC) and to identify biomarkers of response to dietary therapy.

Enrollment

122 estimated patients

Sex

All

Ages

16 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Documented diagnosis with ulcerative colitis from medical records.
  • Self-Identify as American
  • Ages 16-75
  • SCCAI between 3-9 (no greater than 12 bowel movements a day)
  • Fecal calprotectin > 150mg/dl.
  • On stable medications for their disease for the past 3 months
  • Likeability of American foods (sandwiches, BBQ or grilled meats and vegetables, baked potatoes, smoothies, salmon, oatmeal, avocado, soups)
  • No recent Inflammatory Bowel Disease (IBD) related hospitalization in the last month.

Exclusion criteria

  • Diagnosis of Crohn's Disease (CD).
  • Prior ileoanal anastomosis (J-pouch) or diversion
  • No recent hospitalizations on the last 4 weeks
  • No Clostridium difficile or enteric infections on the last 4 weeks
  • No use of probiotics on the last 4 weeks
  • Patients following the specific carbohydrate diet or mediterranean diet or anti-inflammatory diet
  • No active cancer or conditions limiting their ability to follow a diet (heart failure, end stage renal disease)
  • Pregnancy, breastfeeding or planning to become pregnant during study period
  • Use of Total Parenteral Nutrition at the time of screening and during the study period
  • Other significant or life-threatening co-morbidities
  • The need for antibiotic use during the study period
  • Adults unable to consent
  • Ages less than 16 and > 75 years old
  • Prisoners

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

122 participants in 2 patient groups

Catered diet group
Experimental group
Description:
Participants will be in this arm for up to 8 weeks.
Treatment:
Behavioral: Catered diet
Behavioral: Diet guidance sessions
Behavioral: Dietary counseling
Behavioral: Feedback sessions
Diet guidance sessions group
Experimental group
Description:
Participants will be in this arm for up to 8 weeks.
Treatment:
Behavioral: Catered diet
Behavioral: Diet guidance sessions
Behavioral: Dietary counseling
Behavioral: Feedback sessions

Trial contacts and locations

1

Loading...

Central trial contact

Eytan I Stern, MS, RD, LD/N, CNSC; Oriana Damas, MD, MSCTI

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems